Table 1 Patient characteristics
| Â | NSCLC patients (n = 27) |
|---|---|
Age, years | Â |
   Median | 53 |
   Range | 35-67 |
Sex, n (%) | Â |
   Male | 15 (55.6) |
   Female | 12 (44.4) |
Stage, n (%) | Â |
   IIIB | 5 (18.5) |
   IV | 22 (81.5) |
Histology, n (%) | Â |
   Squamous cell carcinoma | 6 (22.2) |
   Adenocarcinoma | 12 (44.4) |
   Adenosquamous cell carcinoma | 2 (7.4) |
   Undifferentiated non-small cell carcinoma | 7 (25.9) |
Karnofski performance status, n (%) | Â |
   70 | 4 (14.8) |
   80 | 10 (37.0) |
   90 | 8 (29.6) |
   100 | 5 (18.5) |
Smoking history, n (%) | Â |
   No | 1 (3.7) |
   Current or former | 26 (96.3) |
RECIST, n (%) | Â |
   Partial response | 9 (33.3) |
   Stable disease | 15 (55.6) |
   Progressive disease | 3 (11.1) |
Survival, days | Â |
   Median progression-free survival | 152 |
   Median overall survival | 315 |